Products - Cervical cancer | Topic | NICE

Showing 3 products

Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Minimally invasive radical hysterectomy for early stage cervical cancer
Status:
In development
Programme:
Interventional procedures guidance
Expected publication date:
16 December 2020
Tisotumab vedotin for treating recurrent or metastatic cervical cancer after systemic therapy [ID3753]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Pembrolizumab with chemotherapy for treating recurrent, persistent or metastatic cervical cancer [ID3798]
Status:
Proposed
Programme:
Technology appraisal guidance
Expected publication date:
TBC